← Back
$BCAX All transactions

Bicara Therapeutics Inc.

▼ SELL 10b5-1 Plan

$ Value

$34K

Shares

1,882

Price

$18

Filed

Jan 26

Insider

Name

Hyep Ivan

Title

Chief Financial Officer

CIK

0002034668

Roles

Officer

Transaction Details

Transaction Date

2026-01-22

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

145,355

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.15 to $18.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. | The shares underlying this option vest in sixteen equal quarterly installments following April 5, 2023, subject to the Reporting Person's continued service on each such vesting date.

Filing Info

Accession No.

0001628280-26-003418

Form Type

4

Issuer CIK

0002023658

Hyep Ivan's History

Date Ticker Type Value
2026-04-21 BCAX M $35K
2026-04-21 BCAX $212K
2026-04-21 BCAX M $0
2026-03-23 BCAX M $35K
2026-03-23 BCAX $170K
2026-03-23 BCAX M $0
2026-03-04 BCAX M $11K
2026-03-04 BCAX $54K
2026-03-04 BCAX M $0
2026-03-03 BCAX M $28K

Other Insiders at BCAX (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $40.0M 2026-02-26
Meisner Lara
Chief Legal Officer
2026-02-02
Cohlhepp Ryan
President and COO
$984K 2026-04-15
Hyep Ivan
Chief Financial Officer
$683K 2026-04-21
Mazumdar Claire
Chief Executive Officer
$1.5M 2026-04-20
Raben David
Chief Medical Officer
$410K 2026-03-25